Correlation Between Geron and Advanced Proteome

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Geron and Advanced Proteome at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Geron and Advanced Proteome into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Geron and Advanced Proteome Therapeutics, you can compare the effects of market volatilities on Geron and Advanced Proteome and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Geron with a short position of Advanced Proteome. Check out your portfolio center. Please also check ongoing floating volatility patterns of Geron and Advanced Proteome.

Diversification Opportunities for Geron and Advanced Proteome

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Geron and Advanced is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Geron and Advanced Proteome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Advanced Proteome and Geron is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Geron are associated (or correlated) with Advanced Proteome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Advanced Proteome has no effect on the direction of Geron i.e., Geron and Advanced Proteome go up and down completely randomly.

Pair Corralation between Geron and Advanced Proteome

If you would invest  0.02  in Advanced Proteome Therapeutics on November 27, 2024 and sell it today you would earn a total of  0.00  from holding Advanced Proteome Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Geron  vs.  Advanced Proteome Therapeutics

 Performance 
       Timeline  
Geron 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Geron has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Advanced Proteome 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Advanced Proteome Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, Advanced Proteome is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Geron and Advanced Proteome Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Geron and Advanced Proteome

The main advantage of trading using opposite Geron and Advanced Proteome positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Geron position performs unexpectedly, Advanced Proteome can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Advanced Proteome will offset losses from the drop in Advanced Proteome's long position.
Geron vs. Viking Therapeutics
Geron vs. TG Therapeutics
Geron vs. X4 Pharmaceuticals
Geron vs. PDS Biotechnology Corp
The idea behind Geron and Advanced Proteome Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Advanced Proteome vs. Hudson Pacific Properties
Advanced Proteome vs. Infosys Ltd ADR
Advanced Proteome vs. Franklin Street Properties
Advanced Proteome vs. NetSol Technologies
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Valuation
Check real value of public entities based on technical and fundamental data
Technical Analysis
Check basic technical indicators and analysis based on most latest market data


 
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY